Randomized, double‐blinded, active‐controlled (darbepoetin alfa), phase 3 study of vadadustat in CKD patients with anemia on hemodialysis in Japan [Abstract and Presentation TH‐OR024]. ASN Kidney Week, Washington, DC, USA; November
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.